Diversified Trust CO Rigel Pharmaceuticals Inc Transaction History

Diversified Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$0.67 - $11.9 $11,028 - $195,874	16,460 Added 109.17%	31,538 $47,000
Q3 2022 Oct 14, 2022	BUY	$1.1 - $12.2 $16,585 - $183,951	15,078 New	15,078 $18,000
Q3 2021 Jan 13, 2022	SELL	$3.5 - $4.5 $117,988 - $151,699	-33,711 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$3.35 - $4.93 $11,621 - $17,102	-3,469 Reduced 9.33%	33,711 $115,000
Q4 2020 Jan 08, 2021	SELL	$2.35 - $3.74 $35,950 - $57,214	-15,298 Reduced 29.15%	37,180 $130,000
Q2 2020 Jul 07, 2020	BUY	$1.41 - $2.05 $57,897 - $84,177	41,062 Added 359.69%	52,478 $96,000
Q4 2019 Jan 09, 2020	BUY	$1.6 - $2.43 $18,265 - $27,740	11,416 New	11,416 $24,000

335K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $3.72B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.